Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide.
ATRI passed our risk checks.
Flawless balance sheet with solid track record.
Share Price & News
How has Atrion's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ATRI has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: ATRI underperformed the US Medical Equipment industry which returned -8% over the past year.
Return vs Market: ATRI underperformed the US Market which returned -12.7% over the past year.
Price Volatility Vs. Market
How volatile is Atrion's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StInsider Buying: The Atrion Corporation (NASDAQ:ATRI) Independent Director Just Bought US$66k Worth Of Shares
2 weeks ago | Simply Wall StDo Atrion's (NASDAQ:ATRI) Earnings Warrant Your Attention?
1 month ago | Simply Wall StDoes Atrion Corporation's (NASDAQ:ATRI) CEO Pay Reflect Performance?
Is Atrion undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ATRI ($615.5) is trading above our estimate of fair value ($263.84)
Significantly Below Fair Value: ATRI is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ATRI is good value based on its PE Ratio (31.1x) compared to the Medical Equipment industry average (36.7x).
PE vs Market: ATRI is poor value based on its PE Ratio (31.1x) compared to the US market (13x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ATRI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ATRI is overvalued based on its PB Ratio (4.8x) compared to the US Medical Equipment industry average (2.9x).
How is Atrion forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Atrion has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Check out Atrion's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
- Explore growth companies in the Healthcare industry.
How has Atrion performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ATRI has high quality earnings.
Growing Profit Margin: ATRI's current net profit margins (23.7%) are higher than last year (22.5%).
Past Earnings Growth Analysis
Earnings Trend: ATRI's earnings have grown by 6.4% per year over the past 5 years.
Accelerating Growth: ATRI's earnings growth over the past year (7.3%) exceeds its 5-year average (6.4% per year).
Earnings vs Industry: ATRI earnings growth over the past year (7.3%) exceeded the Medical Equipment industry 1%.
Return on Equity
High ROE: ATRI's Return on Equity (15.5%) is considered low.
How is Atrion's financial position?
Financial Position Analysis
Short Term Liabilities: ATRI's short term assets ($132.3M) exceed its short term liabilities ($11.3M).
Long Term Liabilities: ATRI's short term assets ($132.3M) exceed its long term liabilities ($12.9M).
Debt to Equity History and Analysis
Debt Level: ATRI is debt free.
Reducing Debt: ATRI has not had any debt for past 5 years.
Debt Coverage: ATRI has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ATRI has no debt, therefore coverage of interest payments is not a concern.
Inventory Level: ATRI has a high level of physical assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if ATRI's debt is covered by short term assets.
What is Atrion's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ATRI's dividend (1.01%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.98%).
High Dividend: ATRI's dividend (1.01%) is low compared to the top 25% of dividend payers in the US market (5.49%).
Stability and Growth of Payments
Stable Dividend: ATRI is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: ATRI is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: ATRI is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ATRI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
David Battat (49yo)
Mr. David A. Battat has been the Chief Executive Officer of ATRION Corp. since May 26, 2011 and has been its President since May 2011. Mr. Battat has been the President of Halkey-Roberts Corporation, a sub ...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD1.54M) is below average for companies of similar size in the US market ($USD3.18M).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
|Executive Chairman||22.17yrs||US$665.27k||8.02% $91.5m|
|Independent Director||32.17yrs||US$132.00k||0.91% $10.4m|
|Independent Director||35.17yrs||US$140.22k||1.52% $17.3m|
|Independent Director||14yrs||US$130.00k||0.11% $1.3m|
|Independent Director||3yrs||US$126.00k||0.027% $308.9k|
Experienced Board: ATRI's board of directors are seasoned and experienced ( 22.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ATRI insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Atrion Corporation's company bio, employee growth, exchange listings and data sources
- Name: Atrion Corporation
- Ticker: ATRI
- Exchange: NasdaqGS
- Founded: 1944
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$1.142b
- Shares outstanding: 1.85m
- Website: https://www.atrioncorp.com
Number of Employees
- Atrion Corporation
- One Allentown Parkway
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ATRI||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Jan 1969|
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company’s cardiovascular products comprise MPS2 Myocardial Protection System that delivers fluids and medications, mixes critical drugs, and controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/03/30 01:01|
|End of Day Share Price||2020/03/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.